The Cohorts · Quarterly vintage
Inception 2024-07-01 · 2.1 years held
Q3 2024 · Top 5.
On 2024-07-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q3 2024 · Top 5 · since inception
+79.3%
CAGR 32.1% annualised
S&P 500 · since inception
+44.8%
CAGR 19.3% annualised
Spread
+34.5%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $196.08 | $5,661.57 | +2787.4% | $357.52 | +82.3% | +16.5% | Read → |
| 2 | BAC | $38.22 | $368.47 | +864.1% | $62.90 | +64.6% | +12.9% | Read → |
| 3 | OXY | $60.42 | $438.58 | +625.9% | $55.09 | -8.8% | -1.8% | Read → |
| 4 | CAT | $319.76 | $2,013.41 | +529.7% | $876.54 | +174.1% | +34.8% | Read → |
| 5 | JNJ | $138.36 | $747.12 | +440.0% | $254.93 | +84.2% | +16.8% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $319.76 → $876.54+174.1%
- JNJ · $138.36 → $254.93+84.2%
- JPM · $196.08 → $357.52+82.3%
Biggest detractors
Where the protocol got it wrong.
- OXY · $60.42 → $55.09-8.8%